We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
BioXcel Therapeutics announces BXCL501 Programme initiative for prevention and treatment of acute agitation using wearable digital devices
Image: BioXcel will investigate the development of using wearable digital device technology such as the Apple Watch, with the goal of enhancing the prevention and treatment of agitation. Photo: courtesy of fancycrave1 from Pixabay.